Phibro Animal Health Corporation (PAHC)
Operating return on assets (Operating ROA)
Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|
Operating income | US$ in thousands | 53,315 | 71,847 | 78,986 | 74,868 | 69,194 |
Total assets | US$ in thousands | 982,184 | 971,397 | 931,699 | 841,325 | 784,100 |
Operating ROA | 5.43% | 7.40% | 8.48% | 8.90% | 8.82% |
June 30, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $53,315K ÷ $982,184K
= 5.43%
Phibro Animal Health Corporation's operating return on assets (operating ROA) has exhibited a declining trend over the past five years, decreasing from 8.82% in 2020 to 5.43% in 2024. This decline indicates that the company's ability to generate operating profits from its assets has weakened over time. The decreasing trend may suggest potential inefficiencies in asset utilization or declining profitability of the company's operations. Investors and stakeholders may want to closely monitor the company's operational efficiency and profitability to ensure sustainable performance in the future.
Peer comparison
Jun 30, 2024
Company name
Symbol
Operating ROA
Phibro Animal Health Corporation
PAHC
5.43%
Abbott Laboratories
ABT
8.85%
AbbVie Inc
ABBV
9.47%
Alkermes Plc
ALKS
19.39%
Amphastar P
AMPH
13.02%
ANI Pharmaceuticals Inc
ANIP
5.19%
Arcus Biosciences Inc
RCUS
-31.05%
Biomarin Pharmaceutical Inc
BMRN
2.31%
Bristol-Myers Squibb Company
BMY
-9.76%
Catalent Inc
CTLT
-7.68%
Catalyst Pharmaceuticals Inc
CPRX
18.47%